Last update 23 Jan 2025

212Pb-Pentixather

Overview

Basic Info

Drug Type
Small molecule drug, Therapeutic radiopharmaceuticals
Synonyms
212Lead-Pentixather
Target
CXCR4
Mechanism
CXCR4 modulators(C-X-C motif chemokine receptor 4 modulators), Ionising radiation emitters
Therapeutic Areas
NeoplasmsRespiratory DiseasesOther Diseases
Active Indication
Carcinoid TumorNeuroendocrine CarcinomaNeuroendocrine neoplasm of lung+ [1]
Inactive Indication-
Originator Organization
University of IowaUniversity of Iowa
Active Organization
The Holden Comprehensive Cancer Center
Inactive Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with 212Pb-Pentixather
NCT05557708
/ Not yet recruitingEarly Phase 1
Phase 1 Trial of Dosimetry Guided 212Pb-pentixather Radioligand Therapy in Patients With Atypical Lung Carcinoids and Neuroendocrine Carcinomas
100 Clinical Results associated with 212Pb-Pentixather
Login to view more data
100 Translational Medicine associated with 212Pb-Pentixather
Login to view more data
100 Patents (Medical) associated with 212Pb-Pentixather
Login to view more data
100 Deals associated with 212Pb-Pentixather
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Carcinoid TumorPhase 1
US
The Holden Comprehensive Cancer Center
01 Jul 2024
Neuroendocrine CarcinomaPhase 1
US
The Holden Comprehensive Cancer Center
01 Jul 2024
Neuroendocrine neoplasm of lungPhase 1
US
The Holden Comprehensive Cancer Center
01 Jul 2024
Small Cell Lung CancerPhase 1
US
The Holden Comprehensive Cancer Center
01 Jul 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free